Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

229
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
229
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

322
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
322
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

273
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
273
Principles of Drug Action01:24

Principles of Drug Action

7.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
7.0K
Social Facilitation01:04

Social Facilitation

33.6K
Not all intergroup interactions lead to negative outcomes. Sometimes, being in a group situation can improve performance. Social facilitation occurs when an individual performs better when an audience is watching than when the individual performs the behavior alone. This typically occurs when people are performing a task for which they are skilled.
33.6K
Stimulants01:29

Stimulants

518
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
518

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contemporary survey of United States poison center treatment recommendations for sodium channel blocking drug poisoning.

Clinical toxicology (Philadelphia, Pa.)·2026
Same author

Factors Associated with Prolonged Prehospital On-Site Time in Adult Trauma Patients: A Nationwide Observational Study in Japan.

JMA journal·2026
Same author

N-Acetylcysteine Dose and Treatment Duration in High-Risk Acetaminophen Ingestions Treated Within Eight Hours: A Retrospective Cohort Study.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same author

Pitfalls in the management of undiagnosed secondary adrenal insufficiency: a case report and review of the literature.

Journal of medical case reports·2026
Same author

Association of Level 3 Personal Protective Equipment With Intubation Success in the Emergency Department.

Acute medicine & surgery·2026
Same author

Prevention of Childhood Poisoning.

Pediatric clinics of North America·2025

Related Experiment Video

Updated: Oct 7, 2025

Determining the Contribution of the Energy Systems During Exercise
11:15

Determining the Contribution of the Energy Systems During Exercise

Published on: March 20, 2012

41.9K

Performance-enhancing drugs and the Olympics.

C James Watson1,2, Genevra L Stone2, Daniel L Overbeek1,3

  • 1Harvard Medical Toxicology Program, Boston Children's Hospital, Boston, MA, USA.

Journal of Internal Medicine
|January 10, 2022
PubMed
Summary
This summary is machine-generated.

The World Anti-Doping Agency (WADA) combats performance-enhancing drug (PED) use in elite sports, facing challenges from evolving substances and testing complexities. Awareness of PEDs and their risks is crucial for healthcare providers.

Keywords:
Olympicsantidopingathleticsdopingmedical historyperformance-enhancing drugstoxicitytoxicology

More Related Videos

Effects of a Novel Neuromuscular Training Intervention on Jump, Sprint, and Change of Direction in Adult Female Soccer Players
10:08

Effects of a Novel Neuromuscular Training Intervention on Jump, Sprint, and Change of Direction in Adult Female Soccer Players

Published on: June 10, 2025

559
An Inertial Measurement Unit Based Method to Estimate Hip and Knee Joint Kinematics in Team Sport Athletes on the Field
06:52

An Inertial Measurement Unit Based Method to Estimate Hip and Knee Joint Kinematics in Team Sport Athletes on the Field

Published on: May 26, 2020

8.2K

Related Experiment Videos

Last Updated: Oct 7, 2025

Determining the Contribution of the Energy Systems During Exercise
11:15

Determining the Contribution of the Energy Systems During Exercise

Published on: March 20, 2012

41.9K
Effects of a Novel Neuromuscular Training Intervention on Jump, Sprint, and Change of Direction in Adult Female Soccer Players
10:08

Effects of a Novel Neuromuscular Training Intervention on Jump, Sprint, and Change of Direction in Adult Female Soccer Players

Published on: June 10, 2025

559
An Inertial Measurement Unit Based Method to Estimate Hip and Knee Joint Kinematics in Team Sport Athletes on the Field
06:52

An Inertial Measurement Unit Based Method to Estimate Hip and Knee Joint Kinematics in Team Sport Athletes on the Field

Published on: May 26, 2020

8.2K

Area of Science:

  • Sports Medicine
  • Pharmacology
  • Public Health

Background:

  • Fair play in sports universally prohibits performance-enhancing drugs (PEDs).
  • The World Anti-Doping Agency (WADA) enforces global anti-doping regulations for elite athletes.
  • Athletes' use of diverse and novel compounds complicates anti-doping enforcement.

Purpose of the Study:

  • To discuss WADA's strategies for preventing PED use during the Olympic Games.
  • To review major classes of PEDs, including their pathophysiology, testing challenges, and toxicities.
  • To inform healthcare providers about PEDs and associated risks.

Main Methods:

  • Review of WADA's anti-doping efforts.
  • Analysis of common PED classes, focusing on scientific and clinical aspects.
  • Discussion of challenges in anti-doping detection and management.

Main Results:

  • WADA employs multifaceted strategies to detect and deter PED use.
  • Understanding the pathophysiology and toxicology of PEDs is essential for effective management.
  • Anti-doping testing faces continuous evolution due to emerging substances and methods.

Conclusions:

  • Healthcare providers must be knowledgeable about PEDs to manage athletes across all levels of sport.
  • Effective anti-doping requires ongoing research and adaptation to new performance-enhancing strategies.
  • Awareness of PED risks is critical for patient safety and maintaining sport integrity.